With a growing range of new vaccines coming on to the market and evidence that some countries simply could not sustain the significant increases in funding required to maintain immunisation programmes, Gavi's first-ever strategy incorporated a detailed review of how best to deploy its growing resources:

STRATEGIC GOALS

Four strategic goals underpinned Phase II

Strategic Goal 1

Contribute to the strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner

Contribute to the strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner

Strategic Goal 2

Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply security

Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply security

Strategic Goal 3

Increase the predictability and sustainability of long-term financing for national immunisation programmes

Increase the predictability and sustainability of long-term financing for national immunisation programmes

Strategic Goal 4 

Increase and assess the added value of Gavi as a public-private global health partnership through improved efficiency, increased advocacy and continued innovation

Increase and assess the added value of Gavi as a public-private global health partnership through improved efficiency, increased advocacy and continued innovation

WORKPLAN, ACTIVITIES, OUTPUTS

With a total budget of US$ 297 million available for the strategy's four-year life cycle, any given year in the Gavi strategy contained up to 100 activities. To help measure progress, these activities are reported against 17 outputs.

The 2010 Work Plan Report highlights the 2010 progress under each output. It is based on the reporting provided by WHO, UNICEF, World Bank, AVI TAC and the Gavi Secretariat. The paper includes an annex table summarising the progress per output against the 2010 work plan targets.

Related downloads

Latest news

Gavi and Alliance partners renew support for immunisation in Mozambique

 A high-level mission comprising Gavi, the Vaccine Alliance, the WHO, UNICEF, Bill & Melinda Gates Foundation and World Bank is scheduled to visit the Republic of Mozambique from 10 December, aiming to renew political commitment towards…

More than US$ 1.8 billion in support for African vaccine manufacturing, catching up missed children and pandemic preparedness approved as Gavi Board steps up efforts to tackle backsliding and fight health emergencies

Gavi’s Board today approved the establishment of the African Vaccine Manufacturing Accelerator (AVMA), a financing instrument that will make up to US$ 1 billion available to support sustainable vaccine manufacturing in Africa.

Gavi expands portfolio, introduces new vaccine programmes to save more lives and support child health

Countries can now submit plans to introduce diphtheria, tetanus and pertussis (DTP)-containing vaccine boosters (DTP boosters) and the six-in-one hexavalent vaccine.

Last updated: 14 Jan 2020

Subscribe to our newsletter